dysport
pharmacy retailing (nz) ltd t/a healthcare logistics - clostridium botulinum type a toxin haemagglutinin complex 500 u - powder for injection - 500 u - active: clostridium botulinum type a toxin haemagglutinin complex 500 u excipient: albumin lactose monohydrate - dysport is also indicated for the symptomatic treatment of axillary hyperhidrosis (excessive sweating)
dysport
pharmacy retailing (nz) ltd t/a healthcare logistics - clostridium botulinum type a toxin haemagglutinin complex 300 u - powder for injection - 300 u - active: clostridium botulinum type a toxin haemagglutinin complex 300 u excipient: albumin lactose monohydrate - dysport is also indicated for the symptomatic treatment of axillary hyperhidrosis (excessive sweating)
dysport for injection 500 uvial
ipsen pharma singapore pte. ltd. - clostridium botulinum type a toxin-haemagglutinin complex - injection, powder, for solution - 500 u/vial - clostridium botulinum type a toxin-haemagglutinin complex 500 u/vial
dysport for injection 300uvial
ipsen pharma singapore pte. ltd. - clostridium botulinum type a toxin-haemagglutinin complex - injection, powder, for solution - clostridium botulinum type a toxin-haemagglutinin complex 300u/vial
clostridium botulinum type d - toxoid
zoetis australia pty ltd - clostridium botulinum type d toxoid - unknown - clostridium botulinum type d toxoid vaccine-toxoid active 0.0 - active constituent
clostridium botulinum type c - toxoid
zoetis australia pty ltd - clostridium botulinum type c toxoid - unknown - clostridium botulinum type c toxoid vaccine-toxoid active 0.0 - active constituent
clostridium botulinum type c awc503
virbac (australia) pty ltd - clostridium botulinum type c - unknown - clostridium botulinum type c vaccine-toxoid active 0.0 - active constituent
clostridium botulinum type d awc360
virbac (australia) pty ltd - clostridium botulinum type d toxoid - unknown - clostridium botulinum type d toxoid vaccine-toxoid active 0.0 - active constituent
ultravac 7 in 1 vaccine
zoetis australia pty ltd - clostridium chauvoei - formol culture; leptospira interrogans serovar pomona; leptospira borgpetersenii serovar hardjo; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - misc. vaccines or anti sera - clostridium chauvoei - formol culture vaccine-microbial active 0.0 p; leptospira interrogans serovar pomona vaccine-microbial active 0.0 p; leptospira borgpetersenii serovar hardjo vaccine-microbial active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - black disease | blackleg | enterotoxaemia (pulpy kidney) | leptospirosis | malignant oedema | tetanus | clostridium perfringens type d | l. hardjo | l. interrogans | l. pomona | l. tarassovi | tetanus vaccination
coopers tasvax 8 in 1 clostridial vaccine for sheep and cattle
intervet australia pty limited - clostridium haemolyticum; clostridium perfringens type b toxoid; clostridium perfringens type c toxoid; clostridium chauvoei whole cell culture; clostridium novyi tybe b toxiod and inactivated cells; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal; aluminium (adjuvant) - misc. vaccines or anti sera - clostridium haemolyticum vaccine-toxoid active 21.2 tcp u/ml; clostridium perfringens type b toxoid vaccine-toxoid active 30.6 tcp u/ml; clostridium perfringens type c toxoid vaccine-toxoid active 15.3 tcp u/ml; clostridium chauvoei whole cell culture vaccine-microbial active 30.0 %ferm/ml; clostridium novyi tybe b toxiod and inactivated cells vaccine-toxiod active 5.95 tcp u/ml; clostridium perfringens type d toxoid vaccine-toxoid active 55.3 tcp u/ml; clostridium septicum - toxoid vaccine-toxoid active 6.4 tcp u/ml; clostridium tetani - toxoid vaccine-toxoid active 3.0 lf u/ml; thiomersal mercury other 0.15 mg/ml; aluminium (adjuvant) mineral-aluminium other 0.0 mg/ml - immunotherapy - cattle | lamb | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | hei - black disease | blackleg | dysentery | enterotoxaemia (pulpy kidney) | haemorrhagic enterotoxaemia | malignant oedema | post parturient gangrene | swelled head | tetanus | tick fever - bovine babesiosis | babesia bigemina | babesia bovis | clostridium perfringens type d | red water | redwater | tetanus vaccination